Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Adma Biologics Inc | 3,262,542 | 3,262,542 | 0 | $27.31M | $32.72M | 20.18% | +$5.42M |
| Faeth Therapeutics Inc | 610,169 | 610,169 | 0 | $15.25M | $18.15M | 11.19% | +$2.89M |
| Palisade Bio Inc | 11,414,285 | 11,414,285 | 0 | $23.86M | $15.41M | 9.50% | -$8.45M |
| Nrx Pharmaceuticals Inc | 4,091,767 | 4,277,200 | +185,433 | $16.74M | $12.49M | 7.70% | -$4.25M |
| Zai Lab LimitedADR(ZLAB) | 450,646 | 450,646 | 0 | $8.56M | $11.87M | 7.32% | +$3.31M |
| Praxis Precision Medicines, Inc.(PRAX) | 33,237 | 33,237 | 0 | $11.13M | $9.68M | 5.97% | -$1.45M |
| Sight Sciences Inc | 970,000 | 970,000 | 0 | $3.66M | $9.08M | 5.60% | +$5.42M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,800,556 | 1,800,556 | 0 | $12.26M | $8.77M | 5.41% | -$3.49M |
| Iovance Biotherapeutics, Inc.(IOVA) | 1,500,000 | 425,000 | -1,075,000 | $6.24M | $6.30M | 3.88% | +$58.5K |
| Structure Therapeutics IncADS | 140,000 | 180,000 | +40,000 | $7.51M | $5.63M | 3.47% | -$1.89M |
| Spyre Therapeutics, Inc.(SYRE) | 70,000 | 62,500 | -7,500 | $6.21M | $5.56M | 3.43% | -$650.2K |
| Cellectis S AADS | 3,281,501 | 3,281,501 | 0 | $9.84M | $4.96M | 3.06% | -$4.89M |
| Aura Biosciences Inc | 764,243 | 764,243 | 0 | $5.43M | $4.80M | 2.96% | -$626.7K |
| Bright Minds Biosciences Inc | 67,500 | 95,000 | +27,500 | $4.74M | $4.73M | 2.92% | -$5.6K |
| Oruka Therapeutics, Inc.(ORKA) | 75,000 | 55,000 | -20,000 | $7.14M | $4.58M | 2.83% | -$2.56M |
| Assembly Biosciences Inc | 175,706 | 175,706 | 0 | $4.83M | $4.13M | 2.55% | -$701.1K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 135,000 | 135,000 | 0 | $4.51M | $2.03M | 1.25% | -$2.48M |
| Foghorn Therapeutics Inc | 200,000 | 200,000 | 0 | $976.0K | $714.0K | 0.44% | -$262.0K |
| Q32 Bio Inc | 0 | 65,000 | +65,000 | $0 | $537.5K | 0.33% | +$537.5K |